1.A Case of Malignant Melanoma with Multiple Myeloma.
Heung Ryeol CHOI ; Yoon Whoa CHO ; Sang Jang LEE ; Byung In RO ; Seong Hong KIM
Annals of Dermatology 1993;5(2):133-136
Malignant melanoma is an uncommon tumor in Korea. To the best of our knowledge, we could not find malignant melanoma with multiple myeloma in Korean literature. A 57-year-old male patient had a 4×5 cm sized, irregular bordered, dark brownish plaque on the left sole, which has extended gradually since about 1 year ago and showed an occasional bleeding tendency. Laboratory examinations revealed a low hemoglobin level, rouleaux formation on peripheral blood, monoclonal gammopathy of IgG-kappa type and Bence-Jones proteinuria. Bone marrow aspiration findings showed markedly increased immature plasma cells suggesting multiple myeloma. Histopathologic findings of the skin biopsy from the left sole revealed proliferation of atypical melanocytes. We performed a surgical excision with a skin graft for malignant melanoma and chemotherapy (melphalan, vincristine and prednisolone) for multiple myeloma.
Biopsy
;
Bone Marrow
;
Drug Therapy
;
Hemorrhage
;
Humans
;
Korea
;
Male
;
Melanocytes
;
Melanoma*
;
Middle Aged
;
Multiple Myeloma*
;
Paraproteinemias
;
Plasma Cells
;
Proteinuria
;
Skin
;
Transplants
;
Vincristine
3.Immunocytochemical analysis for estrogen receptors in the patients with thyroid disease.
Seong Joon KANG ; Seung Sang MOON ; Byung Seon RHOE ; Soo Yong KIM ; Kwang Ro YOON ; Kap Jun YOON
Journal of the Korean Surgical Society 1993;44(3):315-321
No abstract available.
Estrogens*
;
Humans
;
Receptors, Estrogen*
;
Thyroid Diseases*
;
Thyroid Gland*
4.Correlation between Androgenetic Alopecia and Lipid Parameters for Risk Factors of Coronary Artery Disease.
Seong Wook CHOE ; Yang Hyun YOON ; Byung In RO
Korean Journal of Dermatology 2004;42(10):1277-1284
BACKGROUND: The association of androgenetic alopecia and coronary artery disease has not been well documented although many studies have tried to reveal this association. This relationship is still a controversial issue. OBJECTIVES: The aim of this study is to investigate the association between the androgenetic alopecia and lipid parameters for risk factors of coronary artery disease. METHODS: The subjects of this study were 102 patients with androgenetic alopecia who had visited the Department of Dermatology, Pil-dong Hospital, College of medicine, Chung-Ang University during 2 years (from January 2000 to December 2001). The subjects of control group were 40 male individuals who had no androgenetic alopecia, no risk factor of coronary artery disease and no coronary artery disease. RESULTS: 1. There were significant differences in the serum total lipid, phospholipid, triglyceride between the patients and the control group. But there were no significant differences in serum LDL-cholesterol, HDL-cholesterol, and total cholesterol between the two groups. 2. There were significant differences in the serum total lipid, phospholipid, triglyceride between frontal baldness patients and the control group (p<0.05). But there were no significant differences in the serum LDL-cholesterol, HDL-cholesterol, and total cholesterol between the two groups. 3. There were significant differences in the serum total lipid, phospholipid, triglyceride, LDL-cholesterol, and total cholesterol between vertex baldness patients and the control group (p<0.05). But there were no significant differences in serum HDL-cholesterol between two groups. 4. There were no significant differences in the serum total lipid, phospholipid, triglyceride, LDL-cholesterol, HDL-cholesterol and total cholesterol between androgenetic alopecia patients who were increased serum testosterone and the control group. CONCLUSION: These data suggest that androgenetic alopecia involving the vertex scalp is associated with significantly increased total cholesterol and LDL-cholesterol for risk factors of coronary artery disease. We recommend that dermatologists should investigate the lipid parameters, especially total cholesterol and LDL-cholesterol in vertex baldness patients.
Alopecia*
;
Cholesterol
;
Coronary Artery Disease*
;
Coronary Vessels*
;
Dermatology
;
Humans
;
Male
;
Risk Factors*
;
Scalp
;
Testosterone
;
Triglycerides
5.Polyglandular autoimmune syndrome.
Sang Im YOON ; Seong Suk KIM ; Chi Un SONG ; Ki Yang SEONG ; Min Ho SHONG ; Sam Yong KIM ; Young Kun KIM ; Heung Kyu RO
Journal of Korean Society of Endocrinology 1993;8(2):211-216
No abstract available.
6.A Case of Majocchi's Granuloma Caused by Trichophyton rubrum.
Seong Wook CHOE ; Yang Hyun YOON ; Seong Jun SEO ; Chang Kwun HONG ; Byung In RO
Korean Journal of Medical Mycology 2004;9(1):49-53
Dermatophytes usually do not invade beyond the epidermis. However mechanical breakage of the skin resulting from scratching or trauma and immunocompromised state may allow penetration of the fungi into reticular dermis. We report a patient with an unusual manifestation of Trichophyton rubrum infection. A 39-year-old male presented with 3.5x5 cm sized, erythematous, ulcerated lesion on the left heel for about 1 month. Histologic findings of the skin lesion showed granulomatous change and numerous hyphae in the dermis. Trichophyton rubrum was isolated on the fungus culture. The patient was treated with terbinafine (250 mg/day) for 10 weeks, resulting in the clearing of the skin lesion.
Adult
;
Arthrodermataceae
;
Dermis
;
Epidermis
;
Fungi
;
Granuloma*
;
Heel
;
Humans
;
Hyphae
;
Male
;
Skin
;
Trichophyton*
;
Ulcer
7.A Case of Majocchi's Granuloma Caused by Trichophyton rubrum.
Seong Wook CHOE ; Yang Hyun YOON ; Seong Jun SEO ; Chang Kwun HONG ; Byung In RO
Korean Journal of Medical Mycology 2004;9(1):49-53
Dermatophytes usually do not invade beyond the epidermis. However mechanical breakage of the skin resulting from scratching or trauma and immunocompromised state may allow penetration of the fungi into reticular dermis. We report a patient with an unusual manifestation of Trichophyton rubrum infection. A 39-year-old male presented with 3.5x5 cm sized, erythematous, ulcerated lesion on the left heel for about 1 month. Histologic findings of the skin lesion showed granulomatous change and numerous hyphae in the dermis. Trichophyton rubrum was isolated on the fungus culture. The patient was treated with terbinafine (250 mg/day) for 10 weeks, resulting in the clearing of the skin lesion.
Adult
;
Arthrodermataceae
;
Dermis
;
Epidermis
;
Fungi
;
Granuloma*
;
Heel
;
Humans
;
Hyphae
;
Male
;
Skin
;
Trichophyton*
;
Ulcer
8.Multiple brain abscesses treated by extraction of the maxillary molars with chronic apical lesion to remove the source of infection
Ki Hyun JUNG ; Seong Su RO ; Seong Won LEE ; Jae Yoon JEON ; Chang Joo PARK ; Kyung Gyun HWANG
Maxillofacial Plastic and Reconstructive Surgery 2019;41(1):25-
BACKGROUND:
Brain abscess is a life-threatening condition that occurs due to complications during a neurosurgical procedure, direct cranial trauma, or the presence of local or distal infection. Infection in the oral cavity can also be considered a source of brain abscess.CASE PRESENTATION: A 45-year-old male patient was transported with brain abscess in the subcortical white matter. Navigation-guided abscess aspiration and drainage was performed in the right mid-frontal lobe, but the symptoms continued to worsen after the procedure. A panoramic radiograph showed alveolar bone resorption around the maxillary molars. The compromised maxillary molars were extracted under local anesthesia, and antibiotics were applied based on findings from bacterial culture. A brain MRI confirmed that the three brain abscesses in the frontal lobe were reduced in size, and the patient's symptoms began to improve after the extractions.
CONCLUSION
This is a rare case report about multiple uncontrolled brain abscesses treated by removal of infection through the extraction of maxillary molars with odontogenic infection. Untreated odontogenic infection can also be considered a cause of brain abscess. Therefore, it is necessary to recognize the possibility that untreated odontogenic infection can lead to serious systemic inflammatory diseases such as brain abscess. Through a multidisciplinary approach to diagnosis and treatment, physicians should be encouraged to consider odontogenic infections as a potential cause of brain abscesses.
9.Comparison of Cost and Effectiveness between Isotretinoin versus Minocycline in the Treatment of Patients with Acne.
Yang Hyun YOON ; Byung In RO ; Seong Jun SEO ; Myeung Nam KIM ; Chang Kwun HONG
Korean Journal of Dermatology 2005;43(9):1200-1206
BACKGROUND: Pharmacoeconomic analysis is increasingly becoming an integral component of the overall profile of new drugs. Since its introduction in 1981, isotretinoin (13-cis-retinoic acid) has revolutionized the treatment of severe cystic acne by dramatically improving clinical outcomes. Isotretinoin has also been used to treat less-than-severe forms of acne, particularly patients who failed in conventional therapy. PBJECTIVE: This study was undertaken to evaluate the cost-effectiveness of isotretinoin and minocycline for acne treatment. METHOD: We analyzed cost of drug, medical management of the disease and any adverse reactions, average total cost and cure rate (%), cumulative reduction rates (%) of grade, recurrence rate (%), total cost to final cumulative reduction rates (%) of grade and relative cost effectiveness ratio for each drug on the basis of total cost per disease-free period, RESULTS: 1. Total costs of isotretinoin and minocycline group were 795, 354.5+/-87, 382.6won and 432, 271.5+/-3, 892.1won, respectively (p<0.05). 2. Adverse rates of isotretinoin and minocycline group were 88.2% and 25.8%, respectively (p<0.05). 3. Disease free period of isotretinoin and minocycline group were 7.12+/-.51 months and 3.15+/-.62 months, respectively (p<0.05). 4. Rates of cure of isotretinoin and minocycline group were 29/34 (85.3%) and 20/31 (64.5%), respectively (p<0.05). 5. Rates of relapse of isotretinoin and minocycline group were 7/29 (24.1%) and 10/20, respectively (50.0%) (p<0.05). 6. The final cumulative reduction rates of grade of isotretinoin and minocycline group were 96.3+/-4.5% and 65.6+/-2, 6%, respectively (p<0.05). 7. Total costs to of final cumulative reduction rate (%) of grade of treatment between isotretinoin and minocycline group were 5, 331.2+/-24.5won and 5, 986.2+/-02.1won, respectively (p>0.05). 8. Total costs to disease-free period between isotretinoin and minocycline group were 82, 342.7+/-41.2won and 135, 782.3+/-32.3won, respectively (p<0.05). 9. Cost effectiveness ratio of isotretinoin on total costs to disease-free months was 0.65. CONCLUSION: This study has observed better cost-effectiveness of isotretinoin in acne patients in terms of disease-free periods, possibility of cure, rates of relapse, total costs to disease-free period in spite of its higher cost than minocycline.
Acne Vulgaris*
;
Cost-Benefit Analysis
;
Humans
;
Isotretinoin*
;
Minocycline*
;
Recurrence
10.Two Cases of Allopurinol Hypersensitivity Syndrome due to Use of Allopurinol for the Patient with Asymptomatic Hyperuricemia.
Wan Ik CHO ; Yang Hyun YOON ; Myeung Nam KIM ; Seong Jun SEO ; Chang Kwun HONG ; Byung In RO
Korean Journal of Dermatology 2005;43(7):961-964
Allopurinol (4-hydroxypyrazolo[3, 4-d]pyrimidine) is a xanthine oxidase inhibitor and is widely used in the treatment of hyperuricemia. Allopurinol hypersensitivity syndrome (AHS) includes a prolonged illness initially manifested by fever, a prominent cutaneous reaction, eosinophilia, hepatic abnormalities, and decreased renal function. Two patients in our study had a decreased renal function; one due to bilateral polycystic kidneys and the other due to bilateral ureteral stones. Both had received allopurinol for asymptomatic hyperuricemia. Whilst taking this medication, they showed a generalized erythematous, maculopapular eruption with fever, leukocytosis, eosinophilia, a further decrease of renal function and prolonged severe hepatic abnormalities. One patient showed an improvement after they stopped taking allopurinol and were treated with steroids, however, died, due to combined giant cell pneumonia. However, the other patient did improve when they stopped taking allopurinol.
Allopurinol*
;
Eosinophilia
;
Fever
;
Giant Cells
;
Humans
;
Hypersensitivity*
;
Hyperuricemia*
;
Leukocytosis
;
Pneumonia
;
Polycystic Kidney Diseases
;
Steroids
;
Ureter
;
Xanthine Oxidase